Longer time horizons and therapeutic area expertise make philanthropy venture capital an attractive option for biopharmaceutical companies developing new products. It can also de-risk funding rounds ...

Researchers sought to determine whether a plerixafor-sparing regimen would prevent an increase in mobilization failures among patients with MM undergoing HCT.

The longtime voice of the Dodgers missed his first opening day since 1976 in April due to back fractures. He is now facing a ...

New insights into oral HPV infection and cancer risk among men. ( Moffitt Cancer Center, Nature Microbiology) Rigel ...

CSPC Pharmaceutical Group (HK:1093) has released an update. CSPC Pharmaceutical Group has received clinical trial approval in China for their ...

As the New York Yankees and Los Angeles Dodgers prepare to face off in the 2024 World Series, there are plenty of reasons for ...

The new Bruce Springsteen documentary "Road Diary" isn't stuffed with revelations, but it will make you ponder mortality ...

Global Trust Asset Management LLC cut its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 20.0% in the third ...

Germany is known worldwide for its advanced cancer care, which combines state-of-the-art medical technology, highly ...

Amgen Inc.'s Q3 earnings may not be a major upside, but new pipeline drugs and potential breakthroughs could drive growth.

Equities researchers at Leerink Partnrs decreased their Q3 2024 EPS estimates for Bristol-Myers Squibb in a research report ...

"It is dancing in the dark — the analogy of enjoying it," says director Thom Zimny. "And then also you're detached from the world." ...